Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2010 - 2026)

Milestone Scientific's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 12.38% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $32.3 million (down 23.2% YoY), while the FY2025 annual figure was $7.8 million, down 20.32% from the prior year.
• Liabilities and Shareholders Equity came in at $8.0 million for Q1 2026 at Milestone Scientific, up from $7.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $19.1 million in Q1 2022 to a low of $7.8 million in Q4 2025.
• A 5-year average of $11.4 million and a median of $11.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 35.62% in 2023 and grew 5.57% in 2024, its largest moves.
• Milestone Scientific's Liabilities and Shareholders Equity stood at $13.7 million in 2022, then decreased by 17.01% to $11.4 million in 2023, then declined by 13.85% to $9.8 million in 2024, then declined by 20.32% to $7.8 million in 2025, then climbed by 2.01% to $8.0 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $8.0 million, $7.8 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison